BCM
LLY icon

Blume Capital Management’s Eli Lilly LLY Stock Holding History

Blume Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$55.2K Sell
60
-22
-27% -$22.3K 0.01% 191
2025
Q4 		$88.1K Sell
82
-6
-7% -$5.74K 0.02% 154
2025
Q3 		$67.1K Buy
88
+44
+100% +$32.7K 0.01% 174
2025
Q2 		$34.3K Buy
44
+14
+47% +$10.9K 0.01% 205
2025
Q1 		$24.8K Buy
30
+5
+20% +$4.16K 0.01% 218
2024
Q4 		$19.3K Sell
25
-15
-38% -$12.4K ﹤0.01% 228
2024
Q3 		$35.4K Buy
40
+15
+60% +$13.5K 0.01% 208
2024
Q2 		$22.6K Hold
25
– – 0.01% 219
2024
Q1 		$19.4K Hold
25
– – ﹤0.01% 222
2023
Q4 		$14.6K Hold
25
– – ﹤0.01% 231
2023
Q3 		$13.4K Sell
25
-9
-26% -$4.64K ﹤0.01% 234
2023
Q2 		$15.9K Hold
34
– – ﹤0.01% 225
2023
Q1 		$11.7K Hold
34
– – ﹤0.01% 237
2022
Q4 		$12.4K Hold
34
– – ﹤0.01% 239
2022
Q3 		$11K Buy
+34
New +$10.8K ﹤0.01% 237

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Blume Capital Management's LLY Position: Q1 2026 in Review

Blume Capital Management reduced its Eli Lilly (LLY) stake by 27% in Q1 2026, selling an estimated $22.3K and leaving 60 shares worth $55.2K. The position accounts for 0.01% of the portfolio, ranked #191.

Blume Capital Management first reported a position in LLY in Q3 2022 and has held it in 15 quarters since. The position peaked at $88.1K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Blume Capital Management held 60 shares of Eli Lilly worth $55.2K as of Q1 2026.
  • Blume Capital Management sold 22 Eli Lilly shares in Q1 2026, an estimated $22.3K.
  • Eli Lilly made up 0.01% of Blume Capital Management's portfolio in Q1 2026, its #191 holding.
  • Blume Capital Management first reported a position in Eli Lilly in Q3 2022 and has held it in 15 quarters since.
  • Blume Capital Management's Eli Lilly position peaked at $88.1K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Blume Capital Management's 13F filing for Q1 2026, filed 1 May 2026.